Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Intervention Type: Other, Diagnostic Test, Drug
  • Participants: 100000
  • Start Date: April 5, 2021
The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT)
Search for trials
Clinical Trial
  • Status: Recruiting
  • Intervention Type: Other
  • Participants: 1700
  • Start Date: March 22, 2021
DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Procedure, Drug
  • Participants: 36
  • Start Date: December 29, 2020
A Pharmacodynamics-Driven Trial of Talazoparib, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Aberrations in Genes Involved in DNA Damage Response
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Behavioral
  • Participants: 220
  • Start Date: December 1, 2020
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP
Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Procedure, Other, Behavioral
  • Participants: 50
  • Start Date: September 14, 2020
Re-Defining Frailty and Improving Outcomes Through Prehabilitation (RIOT Trial)
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 1/Phase 2
  • Intervention Type: Drug
  • Participants: 146
  • Start Date: July 17, 2020
Phase I/II Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT8009 in Patients With Nectin-4 Expressing Advanced Malignancies
Showing 1-12 of 57